PRIMARY RESEARCH | PUBMED LINKS
DRUG CATEGORY: PEPTIDES+ (BRAIN SUPPORT)
DRUG NAME: SELANK

• FDA Safety Data Sheet not available (experimental peptide).

• Medvedev VE. Optimization of the treatment of anxiety disorders with selank. Zh Nevrol Psikhiatr Im S S Korsakova. 2015 [PubMed Link]

• Medvedev VE. A comparison of the anxiolytic effect and tolerability of selank and phenazepam in the treatment of anxiety disorders. Zh Nevrol Psikhiatr Im S S Korsakova. 2014 [PubMed Link]

• Liapina LA. Comparison of effects of regulatory proline-containing oligopeptides. Specificity of glyprolines, semax, and selank and potential of their practical application. Izv Akad Nauk Ser Biol. 2006 [PubMed Link]

• Siebert A. Tuftsin - Properties and Analogs. Curr Med Chem. 2017 [PubMed Link]

• Zozulia AA. Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurasthenia. Zh Nevrol Psikhiatr Im S S Korsakova. 2008 [PubMed Link]